EE121 Cost-Efficiency and the Opportunity for Expanded Treatment Access with Incremental Increases in Biosimilar Adalimumab and Tocilizumab Use: A European Perspective
Abstract
Authors
K. Shastri K. Clarke M. Ainslie-Garcia N. Ferko